Christine Mannhalter

What is she best known for?

The fields of study she is best known for:

• Gene
• Internal medicine
• Cancer

Christine Mannhalter mostly deals with Internal medicine, Gastroenterology, Risk factor, Surgery and Pathology. Her Internal medicine research is multidisciplinary, incorporating perspectives in Endocrinology and Immunology. Her study in Gastroenterology is interdisciplinary in nature, drawing from both Anesthesia, Polymorphism, Vincristine and Filgrastim, Neutropenia.

Her research integrates issues of Epidemiology, Incidence, Relative risk, TLR4 and Lupus anticoagulant in her study of Risk factor. Her studies deal with areas such as Stroke, Cohort study and Cohort as well as Surgery. Her Pathology research incorporates themes from Myocardial infarction and Bioinformatics.

Her most cited work include:

• Mean platelet volume is an independent risk factor for myocardial infarction but not for coronary artery disease. (387 citations)
• Is Elevated Mean Platelet Volume Associated With a Worse Outcome in Patients With Acute Ischemic Cerebrovascular Events (238 citations)
• The Risk of Recurrent Venous Thromboembolism in Patients with and without Factor V Leiden (186 citations)

What are the main themes of her work throughout her whole career to date?

Her primary scientific interests are in Internal medicine, Immunology, Gastroenterology, Surgery and Genotype. Within one scientific family, Christine Mannhalter focuses on topics pertaining to Endocrinology under Internal medicine, and may sometimes address concerns connected to Methylenetetrahydrofolate reductase. Her work in Immunology is not limited to one particular discipline; it also encompasses Allele.

The concepts of her Gastroenterology study are interwoven with issues in Thrombosis, Venous thrombosis, Case-control study and Vascular disease. Her research in Vascular disease intersects with topics in Stroke and Myocardial infarction. Her Bone marrow study combines topics from a wide range of disciplines, such as Haematopoiesis, Leukemia, Chemotherapy and Transplantation.

She most often published in these fields:

• Internal medicine (49.47%)
• Immunology (21.81%)
• Gastroenterology (21.54%)

What were the highlights of her more recent work (between 2011-2020)?

• Internal medicine (49.47%)
• Immunology (21.81%)
• Cancer research (7.18%)

In recent papers she was focusing on the following fields of study:

The scientist’s investigation covers issues in Internal medicine, Immunology, Cancer research, Platelet and Bone marrow. Christine Mannhalter combines subjects such as Gastroenterology, Surgery, Oncology and Cardiology with her study of Internal medicine. As a part of the same scientific family, Christine Mannhalter mostly works in the field of Surgery, focusing on Risk factor and, on occasion, Protein S deficiency, Thrombophilia and Factor V Leiden.

She focuses mostly in the field of Immunology, narrowing it down to topics relating to Genotype and, in certain cases, Pharmacology. Her Cancer research research includes elements of Haematopoiesis, Stem cell, Leukemia and ABL. Her Platelet study incorporates themes from Blood proteins, Endocrinology and Vascular biology.

Between 2011 and 2020, her most popular works were:

• Morphine decreases clopidogrel concentrations and effects: a randomized, double-blind, placebo-controlled trial. (130 citations)
• Dipeptidylpeptidase IV (CD26) defines leukemic stem cells (LSC) in chronic myeloid leukemia. (116 citations)
• Swarm Intelligence-Enhanced Detection of Non-Small-Cell Lung Cancer Using Tumor-Educated Platelets (99 citations)

In her most recent research, the most cited papers focused on:

• Gene
• Internal medicine
• Cancer

Her primary areas of investigation include Internal medicine, Immunology, Cancer research, In patient and Platelet. The various areas that Christine Mannhalter examines in her Internal medicine study include Surgery and Cardiology. Her Immunology research integrates issues from Clopidogrel, Active metabolite, Biomarker and Genotype.

Her study focuses on the intersection of Genotype and fields such as Antigen with connections in the field of Endocrinology. Her work carried out in the field of Cancer research brings together such families of science as Haematopoiesis, IL-2 receptor, ABL and Pharmacology. She has researched Risk factor in several fields, including Factor V Leiden, Thrombophilia, Venous thrombosis, Protein S deficiency and Lupus anticoagulant.